KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 107 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 12.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $590,000 | +12.4% | 11,776 | -22.3% | 0.40% | +22.2% |
| Q4 2014 | $525,000 | +54.4% | 15,162 | +45.7% | 0.32% | +51.9% |
| Q3 2014 | $340,000 | -15.0% | 10,408 | -0.2% | 0.21% | -10.1% |
| Q2 2014 | $400,000 | -5.0% | 10,426 | -1.7% | 0.24% | -9.2% |
| Q1 2014 | $421,000 | +4.7% | 10,603 | -1.6% | 0.26% | +7.8% |
| Q4 2013 | $402,000 | -20.7% | 10,773 | -3.2% | 0.24% | +0.8% |
| Q3 2013 | $507,000 | +70.7% | 11,130 | +1.1% | 0.24% | +65.1% |
| Q2 2013 | $297,000 | – | 11,004 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
| Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
| Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
| SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
| Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
| PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
| Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
| FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
| Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |